Santhera Pharmaceuticals Holding AG logo

Santhera Pharmaceuticals Holding AG (SANN)

Market Closed
15 Oct, 03:20 PM
SIX SIX
14. 60
CHF
+0.54
+3.8407%
CHF
218.76M Market Cap
- P/E Ratio
- Div Yield
45,171 Volume
-6.11 Eps
14.06 CHF
Previous Close
Add Transaction
Day Range
14 14.6
Year Range
9.57 18.84
Want to track SANN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Santhera Pharmaceuticals Holding AG (SANN) Statistics

Valuation metrics

Market Cap 218.76M
Enterprise value 211.3M
Trailing P/E (ttm) -6.26
Forward P/E 21.79
PEG ratio -0.08
Price/Sales (ttm) 2.09
Price/Book (mrq) -33.2
Enterprise Value/Revenue 2.08
Enterprise Value/EBITDA -62.91

Overview

Shares outstanding 13.39M
Float 10.23M
Shares short -
% Held by insiders 0.16%
% Held by institutions 0.09%
Average volume (10 days) 88.05K
Average volume (90 days) 73.11K

Price summary

52-Week low 9.57
52-Week high 18.84
Beta -0.42
50-Day moving average 15.49
200-Day moving average 15.89

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 3 Jul 2023

Financials

Fiscal year

Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 31 Dec 2018

Profitability

Profit margin -0.31%
Operating margin -0.09%

Operational effectiveness

Return on assets -0.22%
Return on equity 3.55%

Income Statement

Revenue (ttm) 49.02M
Revenue per share (ttm) 7.07
Quarterly revenue growth (yoy) 0.7%
Gross profit (ttm) 6.57M
EBITDA -45.63M
Net income to common (ttm) -65.54M
Diluted EPS (ttm) -2.22
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 18.4M
Total cash per share (mrq) 2.91
Total debt (mrq) 41.22M
Total Debt/Equity (mrq) -6.69
Current ratio (mrq) 1.73%
Book value per share (mrq) -0.43

Cash Flow

Cash flow statement -40.84M
Levered free cash flow (LFCF) -29.87M